Health · 1 views
FDA authorizes first standalone robotic device to draw blood
The U.S. Food and Drug Administration granted marketing authorization for Aletta, the first standalone robotic device capable of drawing…
Source Medical Xpress AI Summary Updated 57m ago
Health 
Story intelligence Beta
Confidence Limited Single-outlet story
Views 1 Community interest
Read time 1 min ~33 words
AI Summary
The U.S. Food and Drug Administration granted marketing authorization for Aletta, the first standalone robotic device capable of drawing blood from a patient’s arm. The authorization was issued to the device’s developer, Vitestro.
Read full article on Medical XpressAI summaries can be wrong sometimes—always verify important details using the source article.
How AI & Automation are usedMore from Health
Continue reading recent Health coverage
- Telemedicine intervention fails to reduce nursing home hospitalizations, study findsContinue reading
- Scientists highlight essential role of mosquito control to tackle increase in mosquito-borne diseases in EuropeContinue reading
- Younger adults with lung cancer more likely to have targetable genetic changes, study findsContinue reading
- How being 'on‑call' for work can disrupt your sleep—even if the call never comesContinue reading
Support HappeningNow
Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.
Support HappeningNow